8 Irish start-ups with a chance to be KPMG's next global tech innovator
KPMG is back with the Irish leg of its Global Tech Innovator 2022 competition, and eight start-ups will battle it out to take the top spot in the national finals next week.
Now in its second year, the Ireland qualifier will take place next Thursday (2 June) with a pitching event that will be broadcast online. The eight start-ups from across the island were selected from more than 40 entries this year.
The winner will represent Ireland at KPMG’s Global Tech Innovator competition at Web Summit in Lisbon this November, competing with 22 other countries and jurisdictions for the overall top prize.
Judges for the Ireland final include Microsoft general manager Anne Sheehan, ESW founder and CEO Tommy Kelly, Atlantic Bridge managing partner and co-founder Elaine Coughlan, Broadstone founding partner Chris McClelland, and KPMG Ireland managing partner Seamus Hand.
Here, we take a closer look at the eight Irish start-ups that could be named the next global tech innovator.
Akara Robotics
Trinity College Dublin spin-out Akara is a growing Irish robotics start-up. As well as its social care robot Stevie, it has built a fully autonomous UV disinfection robot called Violet that aims to reduce turnaround times in clinical settings.
The start-up recently bagged a spot in an EIT Health accelerator, granting it direct access to key European stakeholders to test its product at Tartu University Hospital in Estonia.
Angoka
Angoka is an IoT security company focused on protecting machine-to-machine communications for smart cities and mobility.
The Belfast-based start-up develops technology that protects devices’ identities and safeguards critical communications integrity and data provenance. It also has offices in London and The Hague.
BioSimulytics
This University College Dublin spin-out is developing AI-powered software for drug researchers to predict how a drug molecule will behave in all of its possible crystalline states. Using a combination of machine learning, quantum simulation and cloud computing, BioSimulytics is looking to help biopharma companies get new drugs to the market much faster.
The start-up raised €595,000 in seed funding last September, in a round led by a number of angel investors and Enterprise Ireland. Read More…
